Fasenra is used to treat severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis (EGPA). (EGPA is also known as Churg-Strauss syndrome.) These conditions involve inflammation related to high levels of eosinophils (a type of white blood cell).